Biogen (BIIB)

Cost of Revenue

$3.21B

TTM · Period ending: · USD

BIIB logo

BIIB Cost of Revenue

Latest reported$3.21B
BIIB TTM Cost of Revenue ($0.00 → $3.21B)
High-resolution chart · PNG

BIIB cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
3,212,500,000
2,980,100,000
2,897,000,000
2,984,200,000
2,746,300,000
2,755,900,000
2,676,100,000
2,710,900,000
2,731,800,000
2,368,700,000
2,533,400,000
2,486,000,000
2,295,900,000
2,187,200,000
2,278,300,000
2,367,500,000
2,409,800,000
2,385,500,000
2,109,700,000
1,940,200,000
1,877,500,000
1,828,900,000
1,805,100,000
1,761,600,000
1,742,500,000
1,807,700,000
1,955,400,000
1,996,800,000
2,027,600,000
1,972,300,000
1,816,300,000
1,837,000,000
1,746,200,000
1,691,400,000
1,630,000,000
1,446,900,000
1,493,800,000
1,497,900,000
1,426,300,000
1,432,000,000
1,325,100,000
1,240,900,000
1,240,300,000
1,205,729,000
1,198,368,000
1,204,155,000
1,171,000,000
1,132,324,000
1,064,381,000
1,003,222,000
857,726,000
733,001,000
637,663,000
546,047,000
545,495,000
551,304,000
535,473,000
496,864,000
466,780,000
427,447,000
399,838,000
406,320,000
400,262,000
399,658,000
397,226,000
380,962,000
382,104,000
383,565,000
397,572,000
399,252,000
401,989,000
388,394,000
362,514,000
354,176,000
335,192,000
309,729,000
294,908,000
288,838,000
274,382,000
325,631,000
348,400,000
341,500,000
373,615,000
343,627,000
318,526,000
399,162,000
554,320,000
609,519,000
545,698,000
397,760,000
143,845,000
47,864,000
89,275,000
121,693,000
160,159,000
153,281,000
147,689,000
146,682,000
136,510,000
133,559,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.